On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Glycardial Diagnostics, SL's own share of each project, not the project's full budget.
- Horizon 2020€2.0M · 2 projects
Projects
2 EU-funded projects, newest first. Glycardial Diagnostics, SL led 2 of them as coordinator. Each links to the official record.
- AGLYCCoordinator
The First In Vitro Diagnostic Device for the Early Detection of Cardiac Ischemia
Horizon 2020 · 2019–2022 · Project on CORDIS ↗
€1.9Mtheir share - AGLYCCoordinator
The First In Vitro Diagnostic Device for the Early Detection of Cardiac Ischemia
Horizon 2020 · 2018–2018 · Project on CORDIS ↗
€50ktheir share
Fields it works in
Research fields recorded on its Horizon projects.
- amorphous semiconductors
- business models
- cardiovascular diseases
- mortality
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.